Literature DB >> 29065234

Improvement of refractory pruritus after lipoprotein-apheresis in arthrogryposis-renal failure-cholestasis syndrome.

A Rosales1,2, M Muñoz1, A Madrid1, S Chocron1, J M Hernández3, G Ariceta1.   

Abstract

Accumulation of bile acids can lead to invalidating pruritus in cholestatic patients. Few reports exist on the influence of lipoprotein-apheresis (LA) on plasma level of total bile acids (tBA). We report of significant decrease in tBA levels and drastic improvement of pruritus in a 5-year-old girl with arthrogryposis-renal failure-cholestasis syndrome. We present LA as a suitable rescue treatment option in therapy-refractory cholestasis-associated pruritus, at least as bridge until a long-term solution such as entero-biliary anastomosis or transplantation is possible.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  LDL-apheresis; arthrogryposis-renal failure-cholestasis syndrome; bile acids; cholestasis; lipoprotein-apheresis; pruritus

Mesh:

Substances:

Year:  2017        PMID: 29065234     DOI: 10.1002/jca.21595

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  2 in total

1.  A novel mutation in VPS33B gene causing a milder ARC syndrome phenotype with prolonged survival.

Authors:  Rodrigo Del Brío Castillo; James E Squires; Patrick J McKiernan
Journal:  JIMD Rep       Date:  2019-03-22

2.  Severe renal Fanconi and management strategies in Arthrogryposis-Renal dysfunction-Cholestasis syndrome: a case report.

Authors:  Alejandra Rosales; Maissa Mhibik; Paul Gissen; Oscar Segarra; Susana Redecillas; Gema Ariceta
Journal:  BMC Nephrol       Date:  2018-06-15       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.